Innate lymphoid cells (ILCs) maintain mucosal barrier integrity and are depleted in HIV-1 infection. Interestingly, ILCs are not permissive to HIV-1 or SIV infection, and depletion of ILCs is not a generalized feature of all viral infections. There is thus considerable interest in understanding the exact mechanisms of ILC loss in HIV/SIV infections.
IL-33R+ ILC2s and cKit+ ILC3s in gut-draining mesenteric LNs (MLNs) of SIV-, viremic SIV+ untreated, ART-treated SIV+, and SIV+ Elite Controller (EC) rhesus macaques (RMs) were assessed proportionally by flow cytometry and numerically by immunohistochemistry. To recapitulate HIV/SIV pathology in settings devoid of viral replication, MLN ILCs were assessed in SIV- RMs treated with a CD4-depleting antibody. Some of these animals received DSS, inducing low-grade endotoxemia. In addition we studied a cohort of HIV- persons with idiopathic CD4 lymphophenia (ICL), defined by CD4 counts < 300 cell/ul in the absence of any known immunodeficiency.
cKit+ ILC3s (capable of producing IL-17) were proportionally depleted in the acute (p=0.006, N=10) and chronic SIV+ MLN (p=0.0007, N=11). cKit+ ILC3s were depleted numerically in the acute (p=0.007) and chronic (p=0.007) SIV+ MLN as well . When compared to MLN ILC3 proportions in healthy animals (N=10), control of viremia was associated with reconstitution, or preservation of MLN ILC3s in ART-treated (N=6) or EC RMs (N=5), respectively. Importantly, proportions of MLN ILC3s in all animals correlated inversely with sCD14 in plasma (p= 0.008, r= -0.5). Experimental CD4 depletion in healthy RMs was sufficient to reduce MLN ILC3 percentages (p=0.03, N=2). This was observed more significantly in healthy RMs receiving anti-CD4 and DSS (p=0.0009, N=5), yet not in DSS-treated only RMs (N=2). In striking concordance to CD4-depleted healthy RMs, HIV- subjects with ICL (N=11) displayed lower numbers of blood ILC3 (p=0.0008) and ILC2 (p=0.0001). In MLNs of RMs, cKit+ ILC3s were localized to the CD4 T cell-rich paracortex, and ILC3 proportions in all SIV+ RMs correlated directly with proportions of CD4 T cells in the MLN (p=0.003, r=0.25).
CD4 T cell loss appears to be the main driver of ILC depletion that occurs in HIV/SIV infection as it is also observed in experimental CD4 depletion in primates without SIV infection and also in patients with idiopathic CD4 lymphopenia. These data suggest that mechanisms other than direct viral replication affect ILC homeostasis in SIV/HIV infection.